Asymptomatic and Symptomatic SARS-CoV-2 Infections After BNT162b2 Vaccination in a Routinely Screened Workforce

This study aims to describe an association between the Pfizer-BioNTech (BNT162b2) vaccine and decreased risk of symptomatic and asymptomatic infections with SARS-CoV-2 in hospital employees.

Na minha lista:
Detalhes bibliográficos
Publicado no:JAMA
Main Authors: Tang, Li, Hijano, Diego R., Gaur, Aditya H., Geiger, Terrence L., Neufeld, Ellis J., Hoffman, James M., Hayden, Randall T.
Formato: Artigo
Idioma:Inglês
Publicado em: American Medical Association 2021
Assuntos:
Research Letter
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8220512/
https://ncbi.nlm.nih.gov/pubmed/33956050
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jama.2021.6564
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados